These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 7837849

  • 1. [Future and limits of immunohemotherapy. Great possibilities with apheresis].
    Norda R, Lundkvist I, Söderström T.
    Lakartidningen; 1995 Jan 18; 92(3):155-60. PubMed ID: 7837849
    [No Abstract] [Full Text] [Related]

  • 2. Advances in apheresis therapy for glomerular diseases.
    Yokoyama H, Wada T, Zhang W, Yamaya H, Asaka M.
    Clin Exp Nephrol; 2007 Jun 18; 11(2):122-127. PubMed ID: 17593511
    [Abstract] [Full Text] [Related]

  • 3. [Therapeutic hemapheresis].
    Taraldsrud E, Aandahl GS, Stavem K, Kvalheim G, Jørstad S.
    Tidsskr Nor Laegeforen; 2003 Sep 11; 123(17):2439-42. PubMed ID: 14594145
    [Abstract] [Full Text] [Related]

  • 4. Conventional apheresis therapies: a review.
    Ward DM.
    J Clin Apher; 2011 Sep 11; 26(5):230-8. PubMed ID: 21882233
    [Abstract] [Full Text] [Related]

  • 5. Practical considerations for planning a therapeutic apheresis procedure.
    Shelat SG.
    Am J Med; 2010 Sep 11; 123(9):777-84. PubMed ID: 20541168
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beyond dialysis: current and emerging blood purification techniques.
    Stegmayr B, Ramlow W, Balogun RA.
    Semin Dial; 2012 Sep 11; 25(2):207-13. PubMed ID: 22428812
    [Abstract] [Full Text] [Related]

  • 8. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H.
    Transfus Apher Sci; 2006 Feb 11; 34(1):51-73. PubMed ID: 16412691
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic apheresis in Sweden: update of epidemiology and adverse events.
    Norda R, Stegmayr BG, Swedish Apheresis Group.
    Transfus Apher Sci; 2003 Oct 11; 29(2):159-66. PubMed ID: 12941356
    [Abstract] [Full Text] [Related]

  • 10. WAA apheresis registry in the Czech Republic: two centers experience.
    Bláha M, Pták J, Cáp J, Ceeová V, Masín V, Filip S, Blazek M.
    Transfus Apher Sci; 2009 Aug 11; 41(1):27-31. PubMed ID: 19524488
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic plasmacytapheresis in rheumatology: the status of the problem and developmental outlook].
    Gembitskiĭ EV, Glazunov AV.
    Revmatologiia (Mosk); 1987 Aug 11; (3):3-8. PubMed ID: 3317710
    [No Abstract] [Full Text] [Related]

  • 12. Millennium Memorabilia Issue on Apheresis: part 2. Centrifugal devices, adsorbents, leukocyte filters, and extracorporeal immunomodulations.
    Murabayashi S.
    Ther Apher; 2000 Apr 11; 4(2):71-2. PubMed ID: 10805422
    [No Abstract] [Full Text] [Related]

  • 13. [Methods of plasmapheresis using blood fractionation devices].
    Kalinin NN.
    Sov Med; 1989 Apr 11; (8):40-5. PubMed ID: 2683140
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Is there a need for a national or a global apheresis registry?
    Stegmayr B, Korach JM, Norda R, Rock G, Fadel F.
    Transfus Apher Sci; 2003 Oct 11; 29(2):179-85. PubMed ID: 12941358
    [Abstract] [Full Text] [Related]

  • 16. Current devices and new trends in theraputic apheresis.
    Murabayashi S.
    Ther Apher Dial; 2003 Feb 11; 7(1):36. PubMed ID: 12921112
    [No Abstract] [Full Text] [Related]

  • 17. [Immunomodulation with apheresis technics].
    Liebert A, Quietzsch D, Zimmermann S.
    Allerg Immunol (Leipz); 1986 Feb 11; 32(1):5-18. PubMed ID: 2940851
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.